Women in model | N | Variables | Beta value | P value |
---|---|---|---|---|
All women | 76 | UGT2B101) | -0.6 | 0.902 |
UGT2B7 | 1.8 | 0.631 | ||
UGT2B11 | 4.8 | 0.275 | ||
ESR1 | -3.8 | 0.055 | ||
UGT2B10 2) | -5.6 | 0.005 | ||
BMI | -1.5 | 0.015 | ||
age | -0.4 | 0.074 | ||
50 years or older | 46 | UGT2B11 | 0.2 | 0.987 |
UGT2B101) | 1.0 | 0.946 | ||
UGT2B7 | 3.5 | 0.486 | ||
UGT2B102) | -3.7 | 0.073 | ||
BMI | -1.4 | 0.052 | ||
ESR1 | -6.0 | 0.016 | ||
age | -0.9 | 0.061 | ||
50 years or older, currently on hormone therapy | 11 | UGT2B101) | 7.2 | 0.771 |
UGT2B11 | -5.8 | 0.695 | ||
BMI | -2.9 | 0.103 | ||
UGT2B7 | 6.8 | 0.418 | ||
UGT2B10 2) | -27.0 | 0.000 | ||
ESR1 | -8.1 | 0.011 | ||
age | -0.9 | 0.103 | ||
50 years or older, never used hormone therapy | 28 | UGT2B11 | -0.7 | 0.948 |
UGT2B101) | 3.3 | 0.809 | ||
UGT2B7 | 3.1 | 0.555 | ||
UGT2B102) | -1.4 | 0.607 | ||
BMI | -0.9 | 0.348 | ||
ESR1 | -6.0 | 0.033 | ||
Age | -1.5 | 0.004 | ||
Younger than 50 years | 30 | UGT2B7 | 0.4 | 0.950 |
UGT2B101) | -1.2 | 0.866 | ||
ESR1 | -0.9 | 0.835 | ||
UGT2B11 | 8.4 | 0.225 | ||
BMI | -1.4 | 0.216 | ||
UGT2B10 2) | -6.2 | 0.040 | ||
Age | -0.3 | 0.610 |